Gastrointestinal motor effects of corticotropin-releasing factor in mice

Russell J. Sheldon, Qi Jiang, Frank Porreca, Laurel A. Fisher

Research output: Contribution to journalArticle

47 Citations (Scopus)

Abstract

The present investigation examined the effects of centrally and peripherally administered corticotropin-releasing factor on gastric emptying and gastrointestinal transit in mice. Corticotropin-releasing factor, given either intracerebroventricularly or intrathecally, caused a dose-dependent inhibition of gastric emptyping and gastrointestinal transit. Intravenous or intraperitoneal administration of corticotropin-releasing factor, while 5- to 7-fold less potent than after central injection, produced an equivalent level of effect. α-Helical corticotropin-releasing factor9-41, a corticotropin-releasing factor receptor antagonist, blocked the effects of intracerebroventricularly administered corticotropin-releasing factor when the antagonist was given concurrently by the intracerebroventricular, but not by the intraperitoneal, route. Conversely, corticotropin-releasing factor, when given peripherally, was antagonized equally well by intracerebroventricular or intraperitoneal administration of the antagonist. The inhibition of gastric emptying induced by corticotropin-releasing factor was reduced by pretreatment with the ganglionic blocking agent, chlorisondamine, and in adrenalectomized mice, but this effect was not antagonized by naloxone. These findings provide evidence for an action of corticotropin-releasing factor within the central nervous system, as well as a peripheral site of action, to inhibit gastric emptying in the mouse. The gastrointestinal motor effects of corticotropin-releasing factor are not mediated through opioid mechanisms although their full expression may require intact autonomic innervation and adrenal function.

Original languageEnglish (US)
Pages (from-to)137-151
Number of pages15
JournalRegulatory Peptides
Volume28
Issue number2
DOIs
StatePublished - Apr 24 1990

Fingerprint

Corticotropin-Releasing Hormone
Gastric Emptying
Gastrointestinal Transit
Chlorisondamine
Ganglionic Blockers
Corticotropin-Releasing Hormone Receptors
Neurology
Naloxone
Adrenocorticotropic Hormone
Opioid Analgesics
Stomach
Central Nervous System
Injections

Keywords

  • Gastric emptying
  • Gastrointestinal transit
  • Neuropeptides
  • α-Helical corticotropin-releasing factor

ASJC Scopus subject areas

  • Biochemistry
  • Endocrinology
  • Physiology
  • Neuroscience(all)

Cite this

Gastrointestinal motor effects of corticotropin-releasing factor in mice. / Sheldon, Russell J.; Jiang, Qi; Porreca, Frank; Fisher, Laurel A.

In: Regulatory Peptides, Vol. 28, No. 2, 24.04.1990, p. 137-151.

Research output: Contribution to journalArticle

Sheldon, Russell J. ; Jiang, Qi ; Porreca, Frank ; Fisher, Laurel A. / Gastrointestinal motor effects of corticotropin-releasing factor in mice. In: Regulatory Peptides. 1990 ; Vol. 28, No. 2. pp. 137-151.
@article{cfac92ec03b847f8abaea16e8d5d97e5,
title = "Gastrointestinal motor effects of corticotropin-releasing factor in mice",
abstract = "The present investigation examined the effects of centrally and peripherally administered corticotropin-releasing factor on gastric emptying and gastrointestinal transit in mice. Corticotropin-releasing factor, given either intracerebroventricularly or intrathecally, caused a dose-dependent inhibition of gastric emptyping and gastrointestinal transit. Intravenous or intraperitoneal administration of corticotropin-releasing factor, while 5- to 7-fold less potent than after central injection, produced an equivalent level of effect. α-Helical corticotropin-releasing factor9-41, a corticotropin-releasing factor receptor antagonist, blocked the effects of intracerebroventricularly administered corticotropin-releasing factor when the antagonist was given concurrently by the intracerebroventricular, but not by the intraperitoneal, route. Conversely, corticotropin-releasing factor, when given peripherally, was antagonized equally well by intracerebroventricular or intraperitoneal administration of the antagonist. The inhibition of gastric emptying induced by corticotropin-releasing factor was reduced by pretreatment with the ganglionic blocking agent, chlorisondamine, and in adrenalectomized mice, but this effect was not antagonized by naloxone. These findings provide evidence for an action of corticotropin-releasing factor within the central nervous system, as well as a peripheral site of action, to inhibit gastric emptying in the mouse. The gastrointestinal motor effects of corticotropin-releasing factor are not mediated through opioid mechanisms although their full expression may require intact autonomic innervation and adrenal function.",
keywords = "Gastric emptying, Gastrointestinal transit, Neuropeptides, α-Helical corticotropin-releasing factor",
author = "Sheldon, {Russell J.} and Qi Jiang and Frank Porreca and Fisher, {Laurel A.}",
year = "1990",
month = "4",
day = "24",
doi = "10.1016/0167-0115(90)90013-M",
language = "English (US)",
volume = "28",
pages = "137--151",
journal = "Regulatory Peptides",
issn = "0167-0115",
publisher = "Elsevier",
number = "2",

}

TY - JOUR

T1 - Gastrointestinal motor effects of corticotropin-releasing factor in mice

AU - Sheldon, Russell J.

AU - Jiang, Qi

AU - Porreca, Frank

AU - Fisher, Laurel A.

PY - 1990/4/24

Y1 - 1990/4/24

N2 - The present investigation examined the effects of centrally and peripherally administered corticotropin-releasing factor on gastric emptying and gastrointestinal transit in mice. Corticotropin-releasing factor, given either intracerebroventricularly or intrathecally, caused a dose-dependent inhibition of gastric emptyping and gastrointestinal transit. Intravenous or intraperitoneal administration of corticotropin-releasing factor, while 5- to 7-fold less potent than after central injection, produced an equivalent level of effect. α-Helical corticotropin-releasing factor9-41, a corticotropin-releasing factor receptor antagonist, blocked the effects of intracerebroventricularly administered corticotropin-releasing factor when the antagonist was given concurrently by the intracerebroventricular, but not by the intraperitoneal, route. Conversely, corticotropin-releasing factor, when given peripherally, was antagonized equally well by intracerebroventricular or intraperitoneal administration of the antagonist. The inhibition of gastric emptying induced by corticotropin-releasing factor was reduced by pretreatment with the ganglionic blocking agent, chlorisondamine, and in adrenalectomized mice, but this effect was not antagonized by naloxone. These findings provide evidence for an action of corticotropin-releasing factor within the central nervous system, as well as a peripheral site of action, to inhibit gastric emptying in the mouse. The gastrointestinal motor effects of corticotropin-releasing factor are not mediated through opioid mechanisms although their full expression may require intact autonomic innervation and adrenal function.

AB - The present investigation examined the effects of centrally and peripherally administered corticotropin-releasing factor on gastric emptying and gastrointestinal transit in mice. Corticotropin-releasing factor, given either intracerebroventricularly or intrathecally, caused a dose-dependent inhibition of gastric emptyping and gastrointestinal transit. Intravenous or intraperitoneal administration of corticotropin-releasing factor, while 5- to 7-fold less potent than after central injection, produced an equivalent level of effect. α-Helical corticotropin-releasing factor9-41, a corticotropin-releasing factor receptor antagonist, blocked the effects of intracerebroventricularly administered corticotropin-releasing factor when the antagonist was given concurrently by the intracerebroventricular, but not by the intraperitoneal, route. Conversely, corticotropin-releasing factor, when given peripherally, was antagonized equally well by intracerebroventricular or intraperitoneal administration of the antagonist. The inhibition of gastric emptying induced by corticotropin-releasing factor was reduced by pretreatment with the ganglionic blocking agent, chlorisondamine, and in adrenalectomized mice, but this effect was not antagonized by naloxone. These findings provide evidence for an action of corticotropin-releasing factor within the central nervous system, as well as a peripheral site of action, to inhibit gastric emptying in the mouse. The gastrointestinal motor effects of corticotropin-releasing factor are not mediated through opioid mechanisms although their full expression may require intact autonomic innervation and adrenal function.

KW - Gastric emptying

KW - Gastrointestinal transit

KW - Neuropeptides

KW - α-Helical corticotropin-releasing factor

UR - http://www.scopus.com/inward/record.url?scp=0025239163&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025239163&partnerID=8YFLogxK

U2 - 10.1016/0167-0115(90)90013-M

DO - 10.1016/0167-0115(90)90013-M

M3 - Article

C2 - 2343161

AN - SCOPUS:0025239163

VL - 28

SP - 137

EP - 151

JO - Regulatory Peptides

JF - Regulatory Peptides

SN - 0167-0115

IS - 2

ER -